Menu
GeneBe

rs797045614

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000521.4(HEXB):c.127G>T(p.Ala43Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000278 in 1,441,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

HEXB
NM_000521.4 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.150
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.037356168).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HEXBNM_000521.4 linkuse as main transcriptc.127G>T p.Ala43Ser missense_variant 1/14 ENST00000261416.12
HEXBNM_001292004.2 linkuse as main transcriptc.-376-3941G>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HEXBENST00000261416.12 linkuse as main transcriptc.127G>T p.Ala43Ser missense_variant 1/141 NM_000521.4 P1
HEXBENST00000511181.5 linkuse as main transcriptc.-376-3941G>T intron_variant 1
HEXBENST00000513079.5 linkuse as main transcriptn.192G>T non_coding_transcript_exon_variant 1/62
HEXBENST00000515528.1 linkuse as main transcriptn.182G>T non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000278
AC:
4
AN:
1441022
Hom.:
0
Cov.:
31
AF XY:
0.00000279
AC XY:
2
AN XY:
715740
show subpopulations
Gnomad4 AFR exome
AF:
0.0000305
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000272
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 27, 2014- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 16, 2022The c.127G>T (p.A43S) alteration is located in exon 1 (coding exon 1) of the HEXB gene. This alteration results from a G to T substitution at nucleotide position 127, causing the alanine (A) at amino acid position 43 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicMay 02, 2023BP4, PM2 -
Sandhoff disease Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCounsylDec 07, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.074
T
BayesDel_noAF
Benign
-0.34
Cadd
Benign
2.9
Dann
Benign
0.43
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.037
N
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.037
T
MetaSVM
Benign
-0.31
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.050
N
REVEL
Benign
0.21
Sift
Benign
0.74
T
Sift4G
Benign
0.66
T
Vest4
0.082
MVP
0.41
MPC
0.16
ClinPred
0.040
T
GERP RS
-0.025
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs797045614; hg19: chr5-73981212; API